Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation

Transplantation

Volumn 86, Issue 6, 2008, Pages 784-790

  Hoffmann, Christopher J ^a   Subramanian, Aruna K ^a   Cameron, Andrew M ^a   Engels, Eric A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Immunosuppression; Solid organ transplantation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS C; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; DONOR; ETHNIC GROUP; HEART TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TUMOR; LUNG TRANSPLANTATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RACE; REGISTER; RETROSPECTIVE STUDY; STATISTICS;

ADULT; ANIMALS; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HEART TRANSPLANTATION; HEPATITIS C; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS;

EID: 56049113255     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181837761     Document Type: Article

References (26)

1. Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer 2006; 119: 2685.
2. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
3. OoYH, Gunson BK, Lancashire RJ,et al. Incidenceof cancers following orthotopic liver transplantation in a single center: Comparison with national cancer incidence rates for England and Wales.Transplantation 2005; 80: 759.
4. Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7: 941.
5. Grulich AE, van Leeuwen MT, Falster MO,et al. Incidence ofcancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59.
6. Rosen HR. Hepatitis B and C in the liver transplant recipient: Current understanding and treatment. Liver Transpl 2001; 7(11 suppl 1): S87.
7. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369.
8. El-Serag HB. Hepatocellular carcinoma: An epidemiologic view. J Clin Gastroenterol 2002; 35(5 suppl 2): S72.
9. Yu L, Sloane DA, Guo C, et al. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. Clin Gastroenterol Hepatol 2006; 4: 355.
10. Engels EA, Frisch M, Lubin JH, et al. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002; 31: 536.
11. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocar-cinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15:1198.
12. Brown RS. HepatitisCand liver transplantation. Nature 2005; 436: 973.
13. Glicklich D, Thung SN, Kapoian T, et al. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 1999; 94: 159.
14. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221.
15. Surveillance, Epidemiology, and End Results (SEER) Program. SEER 9 Registries, 2007 November submission. Available at: www seer cancer gov.
16. Vivarelli M, Cucchetti A, Piscaglia F, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression. Liver Transpl 2005; 11: 497.
17. Grasso A, Stigliano R,Morisco F,et al. Liver transplantation and recurrent hepatocellular carcinoma: Predictive value of nodule size in a retrospective and explant study. Transplantation 2006; 81: 1532.
18. Taouli B, Goh JS, Lu Y, et al. Growth rate of hepatocellular carcinoma: Evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 2005; 29: 425.
19. Schreibman IR, Bejarano P, Martinez EJ, et al. Very late recurrence of hepatocellular carcinoma after liver transplantation: Case report and literature review. Transplant Proc 2006; 38:3140.
20. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47.
21. Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study. J Hepatol 2006; 45: 197.
22. El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Disq 2001; 5: 87, vi.
23. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: Natural history and treatment. Semin Liver Dis 2006; 26: 142.
24. Bloom RD, Lake JR. Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients. Am J Transplant 2006; 6: 2232.
25. Sieghart W, Fuereder T, Schmid K, et al. Mammalian target of rapamy-cin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation 2007; 83: 425.
26. Liang TJ, Rehermann B, Seeff LB, et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132: 296.